RPA use cases in healthcare offer valuable insight into why it’s worth passing on some repetitive tasks, like entering patients’ blood test results into specific files and then consistently updating those files, to software robots.
What underlies those higher revenues expected from RPA? PwC mentions a reduction in workforce costs of up to $2 trillion as a result of automating almost half the work activities in companies across the globe.
In a comparison of 12 RPA vendors created by Gartner Peer Insights, UiPath yields not only the most reviews, but also the highest score: 4.6 out of 5. Easy to operate, excellent support services, an active community are just a few of the advantages of using UiPath mentioned by companies from over a dozen industries.
UiPath, the leading Enterprise Robotic Process Automation (RPA) software company, has closed its series C funding co-led by existing investor CapitalG and new investor Sequoia Capital. The company raised $225 million, which currently positions them at a valuation of $3 billion.